Sequenom raises placing to $33M

9 April 2006

San Diego, USA-based Sequenom has announced that the amount of its previously-announced private placement of common stock has been increased $3.0 million to a total of $33.0 million.

Siemens Venture Capital GmbH has agreed to join the previously-announced investors ComVest Investment Partners, Pequot Private Equity Fund IV and LB I Group (an affiliate of Lehman Brothers) in an aggregate commitment for a $33.0 million private placement of common stock and warrants.

The transaction is expected to close May 31 and net proceeds will be used for general working capital needs, say the firm.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight